In osteosarcoma, WWOX binds to RUNX2 via the WW1 domain, thereby inhibiting its transactivation ability [43,44], whereas in breast cancer, the same domain facilitates the cytoplasmic sequestration of SMAD3, which suppresses its transcriptional activity [45]. Here, WWOX is linked to breast carcinoma.